Sort by 'listens'
Latest developments in multiple myeloma with Dr. Ravi Vij
In the first episode of the Multiple Myeloma Curetalk with Dr. Ravi Vij of Washington University, St. Louis, we discuss the latest developments in Multiple Myeloma.
PCOS & Eating Disorders – Managing the Nutritional & Psychological Aspects
Research indicates that the prevalence of #eatingdisorders such as #anorexianervosa, #bulimianervosa and other unspecified eating disorders is higher in women diagnosed with Polycystic Ovary Syndrome (PCOS) compared to that in the general population. Current treatment approaches for #PCOS emphasize the…
Next Generation Targeted Cancer Therapies – The Cellectar Story!
CureTalks launches its new series featuring biotech companies at the cutting edge of innovation and breakthrough research with the purpose of bringing their contributions to the fore and informing the patient community. This talk series will be hosted by Gary…
ASH 2020 Updates: CAR T Cell Therapies in Multiple Myeloma
We kickstart the new year with a discussion on CAR T cells in myeloma treatment with a focus on the CT053, a CAR T-cell therapy targeting the BCMA protein and granted orphan drug status by the U.S. Food and Drug…
Melflufen for Myeloma: A Deep Dive
The FDA recently granted priority review to a new drug application for melflufen (INN melphalan flufenamide), in combination with dexamethasone. Melflufen is intended for use as a first choice for patients with multiple myeloma whose disease is refractory to at…